Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2

Physiology and Behavior

Volumn 97, Issue 3-4, 2009, Pages 446-454

  Singh, Minati ^a   Zimmerman, M Bridget ^b   Beltz, Terry G ^a   Johnson, Alan Kim ^a,c,d  

^a University of Iowa   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Animal models; Anxiety; Behavioral despair; Elevated plus maze; Forced swim test; Obesity; Tail suspension test

Indexed keywords

ADAR2 ENZYME; ADENOSINE DEAMINASE; CORTICOSTERONE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; FORCED SWIMMING TEST; HOPELESSNESS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EDITING;

ADENOSINE DEAMINASE; AFFECTIVE SYMPTOMS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HINDLIMB SUSPENSION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; RNA EDITING; SWIMMING;

EID: 65549103305     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2009.03.029     Document Type: Article

References (93)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed, Text Revision (DSM-IV-TR). (2000), American Psychiatric Association, Washington, D.C.
2. Andreatini R., and Bacellar L.F. The relationship between anxiety and depression in animal models: a study using the forced swimming test and elevated plus-maze. Braz J Med Biol Res 32 (1999) 1121-1126
3. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160 (1999) 1-12
4. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71 (2002) 817-846
5. Berg K.A., Cropper J.D., Niswender C.M., Sanders-Bush E., Emeson R.B., and Clarke W.P. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134 (2001) 386-392
6. Bhalla T., Rosenthal J.J., Holmgren M., and Reenan R. Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nat Struct Mol Biol 11 (2004) 950-956
7. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci U S A 102 (2005) 473-478
8. Burnashev N., Monyer H., Seeburg P.H., and Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8 (1992) 189-198
9. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387 (1997) 303-308
10. Chourbaji S., Brandwein C., Vogt M.A., Dormann C., and Gass P. Evaluation of effects of previous exposure to an acute stressor before testing for depression-like behaviours in mice. Stress 11 (2008) 170-175
11. Cryan J.F., and Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9 (2004) 326-357
12. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29 (2005) 571-625
13. Cryan J.F., Page M.E., and Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182 (2005) 335-344
14. Dal-Zotto S., Marti O., and Armario A. Influence of single or repeated experience of rats with forced swimming on behavioural and physiological responses to the stressor. Behav Brain Res 114 (2000) 175-181
15. Deak T., Bellamy C., D'Agostino L.G., Rosanoff M., McElderry N.K., and Bordner K.A. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav Brain Res 160 (2005) 125-134
16. Delbende C., Delarue C., Lefebvre H., Bunel D.T., Szafarczyk A., Mocaer E., et al. Glucocorticoids, transmitters and stress. Br J Psychiatry Suppl 15 (1992) 24-35
17. Emeson R.B., and Singh M. Adenosine to inosine RNA editing: substrates and consequences. In: Bass B.L. (Ed). RNA Editing: Frontiers in Molecular Biology (2001), Oxford University Press, London 109-138
18. Englander M.T., Dulawa S.C., Bhansali P., and Schmauss C. How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci 25 (2005) 648-651
19. Feng Y., Sansam C.L., Singh M., and Emeson R.B. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol Cell Biol 26 (2006) 480-488
20. Fitzgerald L.W., Iyer G., Conklin D.S., Krause C.M., Marshall A., Patterson J.P., et al. Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21 (1999) 82S-90S
21. Fone K.C., Shalders K., Fox Z.D., Arthur R., and Marsden C.A. Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation. Psychopharmacology (Berl) 123 (1996) 346-352
22. Frey B.N., Andreazza A.C., Nery F.G., Martins M.R., Quevedo J., Soares J.C., et al. The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 18 (2007) 419-430
23. Gardiner K., and Du Y. A-to-I editing of the 5HT2C receptor and behaviour. Brief Funct Genomic Proteomic 5 (2006) 37-42
24. Gerber A., O'Connell M.A., and Keller W. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 3 (1997) 453-463
25. Gerits N., Van Belle W., and Moens U. Transgenic mice expressing constitutive active MAPKAPK5 display gender-dependent differences in exploration and activity. Behav Brain Funct 3 58 (2007) 1-15
26. Gomez F., Lahmame A., de Kloet E.R., and Armario A. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 63 (1996) 327-337
27. Gott J.M., and Emeson R.B. Functions and mechanisms of RNA editing. Annu Rev Genet 34 (2000) 499-531
28. Grippo A.J., Beltz T.G., Weiss R.M., and Johnson A.K. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 59 (2006) 309-316
29. Groenink L., Dirks A., Verdouw P.M., Schipholt M., Veening J.G., van der Gugten J., et al. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol Psychiatry 51 (2002) 875-881
30. Gurevich I., Englander M.T., Adlersberg M., Siegal N.B., and Schmauss C. Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 22 (2002) 10529-10532
31. Gurevich I., Tamir H., Arango V., Dwork A.J., Mann J.J., and Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34 (2002) 349-356
32. Hackler E.A., Airey D.C., Shannon C.C., Sodhi M.S., and Sanders-Bush E. 5-HT(2C) receptor RNA editing in the amygdala of C57BL/6J, DBA/2J, and BALB/cJ mice. Neurosci Res 55 (2006) 96-104
33. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 327 (1984) 1-5
34. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., and Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochem Int 48 (2006) 358-366
35. Heisler L.K., Pronchuk N., Nonogaki K., Zhou L., Raber J., Tung L., et al. Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J Neurosci 27 (2007) 6956-6964
36. Heisler L.K., Zhou L., Bajwa P., Hsu J., and Tecott L.H. Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 6 (2007) 491-496
37. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 (2002) 533-554
38. Iwamoto K., Bundo M., and Kato T. Estimating RNA editing efficiency of five editing sites in the serotonin 2C receptor by pyrosequencing. RNA 11 (2005) 1596-1603
39. Iwamoto K., and Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 346 (2003) 169-172
40. Iwamoto K., Nakatani N., Bundo M., Yoshikawa T., and Kato T. Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res 53 (2005) 69-76
41. Jenck F., Bos M., Wichmann J., Stadler H., Martin J.R., and Moreau J.L. The role of 5-HT2C receptors in affective disorders. Expert Opin Investig Drugs 7 (1998) 1587-1599
42. Jenkins J.A., Williams P., Kramer G.L., Davis L.L., and Petty F. The influence of gender and the estrous cycle on learned helplessness in the rat. Biol Psychol 58 (2001) 147-158
43. Kind P., and Sorensen J. The costs of depression. Int Clin Psychopharmacol 7 (1993) 191-195
44. Kirschbaum C., Wust S., Faig H.G., and Hellhammer D.H. Heritability of cortisol responses to human corticotropin-releasing hormone, ergometry, and psychological stress in humans. J Clin Endocrinol Metab 75 (1992) 1526-1530
45. Kurina L.M., Weiss L.A., Graves S.W., Parry R., Williams G.H., Abney M., et al. Sex differences in the genetic basis of morning serum cortisol levels: genome-wide screen identifies two novel loci specific to women. J Clin Endocrinol Metab 90 (2005) 4747-4752
46. Lai F., Drakas R., and Nishikura K. Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamate-gated ion channel transcripts. J Biol Chem 270 (1995) 17098-17105
47. Lan M.J., McLoughlin G.A., Griffin J.L., Tsang T.M., Huang J.T., Yuan P., et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry (2009) 269-279
48. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 22 (2004) 1001-1005
49. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
50. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44 (1998) 151-162
51. Magiakou M.A., Mastorakos G., Webster E., and Chrousos G.P. The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann N Y Acad Sci 816 (1997) 42-56
52. McAllister-Williams R.H., Ferrier I.N., and Young A.H. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med 28 (1998) 573-584
53. McGrew L., Price R.D., Hackler E., Chang M.S., and Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA. Mol Pharmacol 65 (2004) 252-256
54. Meltzer H.Y. Role of serotonin in depression. Ann N Y Acad Sci 600 (1990) 486-499
55. Millan M.J. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 60 (2005) 441-460
56. Mitra R., and Sapolsky R.M. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci U S A 105 (2008) 5573-5578
57. Moreau J.L., Bos M., Jenck F., Martin J.R., Mortas P., and Wichmann J. 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 6 (1996) 169-175
58. Musselman D.L., and Nemeroff C.B. Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry Suppl 30 (1996) 123-128
59. Niswender C.M., Copeland S.C., Herrick-Davis K., Emeson R.B., and Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274 (1999) 9472-9478
60. Niswender C.M., Herrick-Davis K., Dilley G.E., Meltzer H.Y., Overholser J.C., Stockmeier C.A., et al. RNA editing of the human serotonin 5-HT2C receptor: alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24 (2001) 478-491
61. Ohlson J., Pedersen J.S., Haussler D., and Ohman M. Editing modifies the GABA(A) receptor subunit alpha3. RNA 13 (2007) 698-703
62. Palanza P. Animal models of anxiety and depression: how are females different?. Neurosci Biobehav Rev 25 (2001) 219-233
63. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
64. Pilc A., Chaki S., Nowak G., and Witkin J.M. Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 75 (2008) 997-1006
65. Poland R.E., Rubin R.T., Lesser I.M., Lane L.A., and Hart P.J. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response. Arch Gen Psychiatry 44 (1987) 790-795
66. Pompeiano M., Palacios J.M., and Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 23 (1994) 163-178
67. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47 (1978) 379-391
68. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
69. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
70. Porter R.J., Gallagher P., Watson S., and Young A.H. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 173 (2004) 1-17
71. Price R.D., Weiner D.M., Chang M.S., and Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J Biol Chem 276 (2001) 44663-44668
72. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92 (2001) 179-212
73. Rodgers R.J., Johnson N.J., Champion A.J., and Mills S. Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT. Pharmacol Biochem Behav 54 (1996) 79-84
74. Rueter S.M., Dawson T.R., and Emeson R.B. Regulation of alternative splicing by RNA editing. Nature 399 (1999) 75-80
75. Schmauss C. Serotonin 2C receptors: suicide, serotonin, and runaway RNA editing. Neuroscientist 9 (2003) 237-242
76. Schmauss C., and Howe J.R. RNA editing of neurotransmitter receptors in the mammalian brain. Sci STKE 2002 (2002) PE26
77. Schneider T., and Popik P. Increased depressive-like traits in an animal model of premenstrual irritability. Horm Behav 51 (2007) 142-148
78. Seligman M.E., and Maier S.F. Failure to escape traumatic shock. J Exp Psychol 74 (1967) 1-9
79. Singh M., Kesterson R.A., Jacobs M.M., Joers J.M., Gore J.C., and Emeson R.B. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J Biol Chem 282 (2007) 22448-22459
80. Sodhi M.S., Burnet P.W., Makoff A.J., Kerwin R.W., and Harrison P.J. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol Psychiatry 6 (2001) 373-379
81. Sommer B., Kohler M., Sprengel R., and Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67 (1991) 11-19
82. Spiessl H., Hubner-Liebermann B., and Hajak G. [Depression, a widespread disease. Epidemiology, care situation, diagnosis, therapy and prevention]. Dtsch Med Wochenschr 131 (2006) 35-40
83. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
84. Strekalova T., Spanagel R., Bartsch D., Henn F.A., and Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 29 (2004) 2007-2017
85. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374 (1995) 542-546
86. Tohda M., Nomura M., and Nomura Y. Molecular pathopharmacology of 5-HT2C receptors and the RNA editing in the brain. J Pharmacol Sci 100 (2006) 427-432
87. Torpy D.J., and Chrousos G.P. The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system. Baillieres Clin Rheumatol 10 (1996) 181-198
88. Wang Q., O'Brien P.J., Chen C.X., Cho D.S., Murray J.M., and Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 74 (2000) 1290-1300
89. Wetzler S., and Katz M.M. Problems with the differentiation of anxiety and depression. J Psychiatr Res 23 (1989) 1-12
90. Willner P., Muscat R., and Papp M. An animal model of anhedonia. Clin Neuropharmacol 15 Suppl 1 (1992) 550A-551A Pt A
91. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16 (1992) 525-534
92. Yang W., Wang Q., Kanes S.J., Murray J.M., and Nishikura K. Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. Brain Res Mol Brain Res 124 (2004) 70-78
93. Zarkovic M., Stefanova E., Ciric J., Penezic Z., Kostic V., Sumarac-Dumanovic M., et al. Prolonged psychological stress suppresses cortisol secretion. Clin Endocrinol (Oxf) 59 (2003) 811-816